Target intelligence / Profile preview

Smooth muscle restoration

Molecular classification
Other
01

Overview

Smooth muscle restoration is a therapeutic objective and biological process focused on recovering the structural integrity and contractile function of smooth muscle tissues following injury, degeneration, or disease [4, 21]. It is not a single molecular target but rather a complex physiological outcome achieved through various regenerative strategies, including stem cell transplantation, growth factor delivery, and physical modalities like shockwave therapy [11, 21]. In the context of erectile dysfunction, it involves the regeneration of cavernous smooth muscle cells to restore the smooth muscle-to-collagen ratio necessary for proper blood trapping and erection [7, 20]. In vascular biology, it refers to the return of vascular smooth muscle cells from a synthetic or proliferative phenotype to a contractile phenotype [2, 19]. Key molecular drivers of this process include vascular endothelial growth factor (VEGF), endothelial nitric oxide synthase (eNOS), and transcription factors like myocardin [10, 21]. While not a single molecular target, smooth muscle restoration represents a critical endpoint for evaluating the efficacy of regenerative medicines in urology and vascular biology [5, 16].

Other names
Smooth muscle regenerationSmooth muscle recoveryMyogenic restorationSmooth muscle repair
02

Mechanism of action

Restoration of smooth muscle content and function through paracrine signaling, stem cell differentiation, or activation of regenerative pathways such as the VEGF/eNOS axis and myocardin-mediated transcription [10, 11, 21].

03

Biological functions

Cell proliferation [11, 21]Tissue repair [4, 6]Muscle contraction [2, 19]Angiogenesis [4, 18]Cell differentiation [10, 21]
04

Disease associations

Erectile dysfunction [1, 4, 21]Cardiovascular disease [2, 19]Urinary incontinence [11, 16]Vascular disease [8, 19]Diabetes mellitus [1, 10]
05

Safety considerations

Risk of fibrosis [14]Potential for malignant transformation of stem cells [4, 6]Immunogenicity [4, 21]Inconsistent cell retention in target tissues [4, 21]
06

Interacting drugs

Adipose-derived stem cells (ADSCs) [4, 21]

5 more in the full profile.

07

Biomarkers

Alpha-smooth muscle actin (α-SMA) [10, 21]Desmin [7, 21]Smooth muscle myosin heavy chain (SMMHC) [16]Intracavernosal pressure (ICP) [7, 20]Smooth muscle-to-collagen ratio [5, 20]

Beyond the preview

Go deeper on Smooth muscle restoration.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Smooth muscle restoration.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call